Regeneron Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Regeneron Pharmaceuticals, Inc.

May-01	Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination REGN GlobeNewswire
May-01	Dupixent (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases REGN GlobeNewswire